Sequential cisplatin-gemcitabine-docetaxel vs docetaxel-gemcitabine in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Interim results of an ongoing phase II trial.

被引：0
|
作者：
Binder, D
Beinert, T
Schweisfurth, H
Grah, C
Temmesfeld-Wollbrock, B
Müller-Hagen, G
Schäper, C
Schürmann, D
Suttorp, N
机构：
[1] Med Klin Infektiolog, Berlin, Germany
[2] Klin Warternberg, Wartenberg, Germany
[3] Med Klin, Cottbus, Germany
[4] Med Klin Kardiol Pneumol, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7113
引用
收藏
页码：644S / 644S
页数：1
相关论文
共 50 条
  • [31] Preliminary results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)
    Bernardini, I
    Rinaldi, M
    Crinò, L
    Nardi, M
    De Marinis, F
    Tonato, M
    Sguotti, C
    Vallauri, L
    Scagliotti, G
    Novello, S
    LUNG CANCER, 2005, 49 : S239 - S239
  • [32] Preliminary results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC).
    Rinaldi, M
    Novello, S
    Bernardini, I
    Crinò, L
    Nardi, M
    de Marinis, F
    Tonato, M
    Sguotti, C
    Marini, L
    Scagliotti, GV
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 651S - 651S
  • [33] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic non-small-cell lung cancer: A multicenter phase II study
    Costa, A
    Almodovar, T
    Seada, J
    Barata, F
    Teixeira, E
    Queiroga, H
    Pires, S
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 117 - 120
  • [34] Docetaxel and gefitinib in the first-line treatment of elderly patients (≥ 70) with advanced non-small cell lung cancer (ANSCLC):: Results of phase II trial.
    Beple, G
    Williams, CC
    Chiappori, A
    Antonia, SJ
    Haura, EB
    Mahany, JJ
    Galloway, T
    Simon, GR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 659S - 659S
  • [35] Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Dane, Faysal
    Isikdogan, Abdurrahman
    Ustaalioglu, Basak Oven
    Coskun, Ugur
    Yumuk, Perran Fulden
    Dogu, Gamze Gokoz
    Ozdemir, Nuriye Yildirim
    Sevinc, Alper
    Gumus, Mahmut
    Ozkan, Metin
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    TUMORI JOURNAL, 2010, 96 (03): : 400 - 404
  • [36] RANDOMIZED PHASE II TRIAL OF SAFETY OF BIWEEKLY DOCETAXEL/CISPLATIN VS GEMCITABINE/CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WHO ARE ELDERLY OR POOR PERFORMANCE STATUS
    Kim, Hoon K.
    Jang, Joung-Soon
    Cho, Byoung Chul
    Lee, Kyung Hee
    Yun, Hwan Jung
    Woo, In Sook
    Kim, Chi Hong
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S573 - S573
  • [37] Gemcitabine and docetaxel as concomitant or sequential first-line therapy of advanced non-small cell lung cancer:: Updated results of a randomized study
    Manegold, C
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Piiz, L
    LUNG CANCER, 2005, 49 : S36 - S36
  • [38] A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer
    Pallis, AG
    Agelidou, A
    Papakotoulas, P
    Tsaroucha, A
    Agelidou, M
    Agelaki, S
    Androulakis, N
    Vamvakas, L
    Gerogianni, A
    Kotsakis, A
    Kentepozidis, N
    Georgoulias, V
    LUNG CANCER, 2006, 52 (02) : 165 - 171
  • [39] Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC)
    Ferrer, N.
    Cobo, M.
    Paredes, A.
    Mendez, M.
    Munoz-Langa, J.
    Rueda, A.
    de Mon, M. Alvarez
    Sanchez-Hernandez, A.
    Gallego, R.
    Torrego, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
    Casal Rubio, Joaquin
    Vazquez, S.
    Vazquez, F.
    Amenedo, M.
    Firvida, J. L.
    Mel, J. R.
    Huidobro, G.
    Alvarez, E.
    Lazaro, M.
    Alonso, G.
    Fernandez, I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 379 - 384
12345